{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:26:48Z","timestamp":1792592808527,"version":"4.5.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1053\/j.ackd.2005.07.011","type":"journal-article","created":{"date-parts":[[2005,9,29]],"date-time":"2005-09-29T13:42:55Z","timestamp":1128001375000},"page":"353-365","source":"Crossref","is-referenced-by-count":273,"title":["Progression in Chronic Kidney Disease"],"prefix":"10.1053","volume":"12","author":[{"given":"Allison A.","family":"Eddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.ackd.2005.07.011_bib1","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2005.07.011_bib2","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1523-1755.2005.67097.x","article-title":"Pathways to nephron loss starting from glomerular diseases-insights from animal models","volume":"67","author":"Kriz","year":"2005","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2005.07.011_bib3","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/0272-6386(95)90013-6","article-title":"Methylprednisolone retards the progression of inherited polycystic kidney disease in rodents","volume":"25","author":"Gattone","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2005.07.011_bib4","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1046\/j.1523-1755.1999.055003945.x","article-title":"Mycophenolate mofetil prevents the progressive renal failure induced by 5\/6 renal ablation in rats","volume":"55","author":"Romero","year":"1999","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2005.07.011_bib5","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1084\/jem.190.12.1813","article-title":"Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice","volume":"190","author":"Tesch","year":"1999","journal-title":"J Exp Med"},{"key":"10.1053\/j.ackd.2005.07.011_bib6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1172\/JCI4876","article-title":"Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis","volume":"103","author":"Tesch","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ackd.2005.07.011_bib7","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1097\/01.ASN.0000069223.98703.8E","article-title":"Anti-monocyte chemoattractant protein-1 gene therapy attenuates renal injury induced by protein-overload proteinuria","volume":"14","author":"Shimizu","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2005.07.011_bib8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1172\/JCI0214040","article-title":"A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation","volume":"109","author":"Anders","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ackd.2005.07.011_bib9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/01.ASN.0000111246.87175.32","article-title":"Chemokine receptor CCR1 but not CCR5 mediates leukocyte recruitment and subsequent renal fibrosis after unilateral ureteral obstruction","volume":"15","author":"Eis","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2005.07.011_bib10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0002-9440(10)63292-0","article-title":"Blockade of CCR2 ameliorates progressive fibrosis in kidney","volume":"165","author":"Kitagawa","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1053\/j.ackd.2005.07.011_bib11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1523-1755.1999.00543.x","article-title":"Monocyte chemoattractant protein-1 mediates collagen deposition in experimental glomerulonephritis by transforming growth factor-beta","volume":"56","author":"Schneider","year":"1999","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2005.07.011_bib12","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1523-1755.2003.00781.x","article-title":"Gene transfer of truncated IkappaBalpha prevents tubulointerstitial injury","volume":"63","author":"Takase","year":"2003","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2005.07.011_bib13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/ndt\/gfg533","article-title":"Proteinuria and interstitial injury","volume":"19","author":"Eddy","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ackd.2005.07.011_bib14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1046\/j.1523-1755.2002.00419.x","article-title":"P-selectin-dependent macrophage migration into the tubulointerstitium in unilateral ureteral obstruction","volume":"62","author":"Naruse","year":"2002","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2005.07.011_bib15","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1681\/ASN.V9101805","article-title":"Improved survival and amelioration of nephrotoxic nephritis in intercellular adhesion molecule-1 knockout mice","volume":"9","author":"Janssen","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2005.07.011_bib16","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0002-9440(10)64403-3","article-title":"Treatment with an antibody to VLA-1 integrin reduces glomerular and tubulointerstitial scarring in a rat model of crescentic glomerulonephritis","volume":"161","author":"Cook","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1053\/j.ackd.2005.07.011_bib17","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.4049\/jimmunol.169.4.2026","article-title":"Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells","volume":"169","author":"Tsuboi","year":"2002","journal-title":"J Immunol"},{"key":"10.1053\/j.ackd.2005.07.011_bib18","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/01.ASN.0000121781.89599.16","article-title":"Signaling danger","volume":"15","author":"Anders","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2005.07.011_bib19","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1097\/01.ASN.0000051597.27127.A1","article-title":"Administration of a soluble recombinant complement C3 inhibitor protects against renal disease in MRL\/lpr mice","volume":"14","author":"Bao","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2005.07.011_bib20","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1523-1755.2001.030002587.x","article-title":"PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction","volume":"30","author":"Oda","year":"2001","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2005.07.011_bib21","doi-asserted-by":"crossref","first-page":"22595","DOI":"10.1074\/jbc.M313004200","article-title":"The low density lipoprotein receptor-related protein is a motogenic receptor for plasminogen activator inhibitor-1","volume":"279","author":"Degryse","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1053\/j.ackd.2005.07.011_bib22","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1097\/01.ASN.0000064292.37793.FB","article-title":"Urokinase receptor deficiency accelerates fibrosis in obstructive nephropathy","volume":"14","author":"Zhang","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2005.07.011_bib23","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1172\/JCI200215045","article-title":"Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis","volume":"110","author":"Nishida","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ackd.2005.07.011_bib24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1172\/JCI200522675","article-title":"Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair","volume":"115","author":"Duffield","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ackd.2005.07.011_bib25","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1681\/ASN.V961008","article-title":"Chronic obstructive uropathy in severe combined immunodeficient (SCID) mice","volume":"9","author":"Shappell","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2005.07.011_bib26","first-page":"1169","article-title":"Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis","volume":"148","author":"Tang","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1053\/j.ackd.2005.07.011_bib27","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/nm888","article-title":"BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury","volume":"9","author":"Zeisberg","year":"2003","journal-title":"Nat Med"},{"key":"10.1053\/j.ackd.2005.07.011_bib28","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00418-003-0513-8","article-title":"Localisation and phenotypical characterisation of collagen-producing cells in TGF-beta1-induced renal interstitial fibrosis","volume":"119","author":"Chai","year":"2003","journal-title":"Histochem Cell Biol"},{"key":"10.1053\/j.ackd.2005.07.011_bib29","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1172\/JCI200320530","article-title":"Epithelial-mesenchymal transition and its implications for fibrosis","volume":"112","author":"Kalluri","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ackd.2005.07.011_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.ASN.0000106015.29070.E7","article-title":"Epithelial to mesenchymal transition in renal fibrogenesis","volume":"15","author":"Liu","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2005.07.011_bib31","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1172\/JCI0215518","article-title":"Evidence that fibroblasts derive from epithelium during tissue fibrosis","volume":"110","author":"Iwano","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ackd.2005.07.011_bib32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1006\/mthe.2000.0251","article-title":"Conditional abatement of tissue fibrosis using nucleoside analogs to selectively corrupt DNA replication in transgenic fibroblasts","volume":"3","author":"Iwano","year":"2001","journal-title":"Mol Ther"},{"key":"10.1053\/j.ackd.2005.07.011_bib33","doi-asserted-by":"crossref","first-page":"F7","DOI":"10.1152\/ajprenal.00451.2003","article-title":"Hepatocyte growth factor in kidney fibrosis","volume":"287","author":"Liu","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1053\/j.ackd.2005.07.011_bib34","doi-asserted-by":"crossref","first-page":"F349","DOI":"10.1152\/ajprenal.00154.2002","article-title":"Delayed administration of hepatocyte growth factor reduces renal fibrosis in obstructive nephropathy","volume":"284","author":"Yang","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1053\/j.ackd.2005.07.011_bib35","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1097\/01.ASN.0000141962.44300.3A","article-title":"Hepatocyte growth factor ameliorates renal interstitial inflammation in rat remnant kidney by modulating tubular expression of macrophage chemoattractant protein-1 and RANTES","volume":"15","author":"Gong","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2005.07.011_bib36","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1101\/gad.9.22.2795","article-title":"A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye","volume":"9","author":"Dudley","year":"1995","journal-title":"Genes Dev"},{"key":"10.1053\/j.ackd.2005.07.011_bib37","doi-asserted-by":"crossref","first-page":"8094","DOI":"10.1074\/jbc.M413102200","article-title":"Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney","volume":"280","author":"Zeisberg","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1053\/j.ackd.2005.07.011_bib38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1681\/ASN.2004050395","article-title":"Bone morphogenic protein-7 inhibits monocyte-stimulated TGF-beta1 generation in renal proximal tubular epithelial cells","volume":"16","author":"Zhang","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2005.07.011_bib39","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1046\/j.1523-1755.2001.059003876.x","article-title":"Relaxin decreases renal interstitial fibrosis and slows progression of renal disease","volume":"59","author":"Garber","year":"2001","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2005.07.011_bib40","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1111\/j.1523-1755.2004.00628.x","article-title":"Relaxin-1-deficient mice develop an age-related progression of renal fibrosis","volume":"65","author":"Samuel","year":"2004","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2005.07.011_bib41","doi-asserted-by":"crossref","first-page":"F59","DOI":"10.1152\/ajprenal.00157.2002","article-title":"Relaxin increases ubiquitin-dependent degradation of fibronectin in vitro and ameliorates renal fibrosis in vivo","volume":"285","author":"McDonald","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1053\/j.ackd.2005.07.011_bib42","doi-asserted-by":"crossref","first-page":"8015","DOI":"10.1073\/pnas.120055097","article-title":"Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db\/db diabetic mice","volume":"97","author":"Ziyadeh","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.ackd.2005.07.011_bib43","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1523-1755.2004.00393.x","article-title":"Treatment with anti-TGF-beta antibody ameliorates chronic progressive nephritis by inhibiting Smad\/TGF-beta signaling","volume":"65","author":"Fukasawa","year":"2004","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2005.07.011_bib44","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1747.2003.12517.x","article-title":"Latency-associated peptide prevents skin fibrosis in murine sclerodermatous graft-versus-host disease, a model for human scleroderma","volume":"121","author":"Zhang","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1053\/j.ackd.2005.07.011_bib45","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1046\/j.1523-1755.2003.00045.x","article-title":"Blockade of TGF-beta action ameliorates renal dysfunction and histologic progression in anti-GBM nephritis","volume":"64","author":"Zhou","year":"2003","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2005.07.011_bib46","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1172\/JCI200319270","article-title":"Targeted disruption of TGF-beta1\/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction","volume":"112","author":"Sato","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ackd.2005.07.011_bib47","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1681\/ASN.V102271","article-title":"Renal expression of fibrotic matrix proteins and of transforming growth factor-beta (TGF-beta) isoforms in TGF-beta transgenic mice","volume":"10","author":"Mozes","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2005.07.011_bib48","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1097\/01.ASN.0000067632.04658.B8","article-title":"Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model","volume":"14","author":"Lan","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2005.07.011_bib49","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1073\/pnas.90.2.770","article-title":"Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death","volume":"90","author":"Kulkarni","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.ackd.2005.07.011_bib50","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1523-1755.2004.00381.x","article-title":"Divergent effects of low versus high dose anti-TGF-beta antibody in puromycin aminonucleoside nephropathy in rats","volume":"65","author":"Ma","year":"2004","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2005.07.011_bib51","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1097\/01.ASN.0000099373.33259.B2","article-title":"Downregulation of Smad transcriptional corepressors SnoN and Ski in the fibrotic kidney","volume":"14","author":"Yang","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2005.07.011_bib52","doi-asserted-by":"crossref","first-page":"8687","DOI":"10.1073\/pnas.0400035101","article-title":"Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice","volume":"101","author":"Fukasawa","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.ackd.2005.07.011_bib53","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1097\/01.ASN.0000034912.55186.EC","article-title":"How to fully protect the kidney in a severe model of progressive nephropathy","volume":"13","author":"Zoja","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2005.07.011_bib54","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1172\/JCI0215493","article-title":"In vivo bradykinin B2 receptor activation reduces renal fibrosis","volume":"110","author":"Schanstra","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ackd.2005.07.011_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1523-1755.2004.00701.x","article-title":"Aldosterone in the development and progression of renal injury","volume":"66","author":"Hollenberg","year":"2004","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2005.07.011_bib56","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1097\/01.ASN.0000130565.69170.85","article-title":"Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis","volume":"15","author":"Yokoi","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2005.07.011_bib57","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1681\/ASN.2004040339","article-title":"Connective tissue growth factor expressed in tubular epithelium plays a pivotal role in renal fibrogenesis","volume":"16","author":"Okada","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2005.07.011_bib58","doi-asserted-by":"crossref","first-page":"F209","DOI":"10.1152\/ajprenal.00032.2002","article-title":"Plasminogen activator inhibitor-1 and the kidney","volume":"283","author":"Eddy","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1053\/j.ackd.2005.07.011_bib59","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1111\/j.1523-1755.2005.00327.x","article-title":"Multi-functionality of PAI-1 in fibrogenesis","volume":"67","author":"Matsuo","year":"2005","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2005.07.011_bib60","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1172\/JCI200318038","article-title":"A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis","volume":"112","author":"Huang","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ackd.2005.07.011_bib61","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1681\/ASN.2004060492","article-title":"Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1","volume":"16","author":"Ma","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2005.07.011_bib62","series-title":"Mechanisms and Clinical Management of Chronic Renal Failure","article-title":"Experimental insights into the mechanisms of tubulo-interstitial scarring","author":"Jernigan","year":"2000"},{"key":"10.1053\/j.ackd.2005.07.011_bib63","series-title":"Pediatr Nephrol","article-title":"Can renal fibrosis be reversed?","author":"Eddy","year":"2006"},{"key":"10.1053\/j.ackd.2005.07.011_bib64","first-page":"245","article-title":"Experimental diffuse interstitial renal fibrosis. A biochemical approach","volume":"59","author":"Gonz\u00e1lez-Avila","year":"1988","journal-title":"Lab Invest"},{"key":"10.1053\/j.ackd.2005.07.011_bib65","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1046\/j.1523-1755.2000.00097.x","article-title":"Ischemic acute renal failure","volume":"57","author":"Forbes","year":"2000","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2005.07.011_bib66","first-page":"1381","article-title":"Renal extracellular matrix accumulation in acute puromycin aminonucleoside nephrosis in rats","volume":"141","author":"Jones","year":"1992","journal-title":"Am J Pathol"},{"key":"10.1053\/j.ackd.2005.07.011_bib67","first-page":"203","article-title":"Enalapril accelerates remodeling of the renal interstitium after release of unilateral ureteral obstruction in rats","volume":"16","author":"Koo","year":"2003","journal-title":"J Nephrol"},{"key":"10.1053\/j.ackd.2005.07.011_bib68","doi-asserted-by":"crossref","first-page":"15074","DOI":"10.1074\/jbc.271.25.15074","article-title":"Matrix metalloproteinase 2 (gelatinase A) regulates glomerular mesangial cell proliferation and differentiation","volume":"271","author":"Turck","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1053\/j.ackd.2005.07.011_bib69","series-title":"J Am Soc Nephrol","first-page":"37A","article-title":"Transgenic renal proximal tubular cell expression of active matrix metalloproteinase-2 drives epithelial-mesenchymal transition and interstitial fibrosis","author":"Cheng","year":"2004"},{"key":"10.1053\/j.ackd.2005.07.011_bib70","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1172\/JCI0216219","article-title":"Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy","volume":"110","author":"Yang","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ackd.2005.07.011_bib71","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/S0002-9440(10)64327-1","article-title":"Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation","volume":"162","author":"Cheng","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1053\/j.ackd.2005.07.011_bib72","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0002-9440(10)64318-0","article-title":"Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium","volume":"162","author":"McGuire","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1053\/j.ackd.2005.07.011_bib73","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1523-1755.2004.00707.x","article-title":"Plasmin is not protective in experimental renal interstitial fibrosis","volume":"66","author":"Edgtton","year":"2004","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2005.07.011_bib74","first-page":"36A","article-title":"Plasmin(ogen) promotes renal interstitial fibrosis by inducing epithelial-to-mesenchymal transition","volume":"15","author":"Zhang","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2005.07.011_bib75","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1681\/ASN.V124736","article-title":"TIMP-1 deficiency does not attenuate interstitial fibrosis in obstructive nephropathy","volume":"12","author":"Kim","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2005.07.011_bib76","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0002-9440(10)63196-3","article-title":"The plasminogen activation system reduces fibrosis in the lung by a hepatocyte growth factor-dependent mechanism","volume":"164","author":"Hattori","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1053\/j.ackd.2005.07.011_bib77","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1089\/10430349950016960","article-title":"Treatment of bleomycin-induced pulmonary fibrosis by transfer of urokinase-type plasminogen activator genes","volume":"10","author":"Sisson","year":"1999","journal-title":"Hum Gene Ther"},{"key":"10.1053\/j.ackd.2005.07.011_bib78","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1006\/mthe.2000.0210","article-title":"Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy","volume":"2","author":"Salgado","year":"2000","journal-title":"Mol Ther"},{"key":"10.1053\/j.ackd.2005.07.011_bib79","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1172\/JCI200317740","article-title":"Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis","volume":"112","author":"Canbay","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ackd.2005.07.011_bib80","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1681\/ASN.V122275","article-title":"Expression of apoptosis-related genes and proteins in experimental chronic renal scarring","volume":"12","author":"Yang","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2005.07.011_bib81","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1046\/j.1523-1755.2001.060003924.x","article-title":"Renal cell apoptosis in chronic obstructive uropathy","volume":"60","author":"Truong","year":"2001","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2005.07.011_bib82","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1097\/01.ASN.0000061595.28546.A0","article-title":"Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice","volume":"14","author":"Lin","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2005.07.011_bib83","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1172\/JCI17856","article-title":"Bone marrow stem cells contribute to repair of the ischemically injured renal tubule","volume":"112","author":"Kale","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ackd.2005.07.011_bib84","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1097\/01.ASN.0000128974.07460.34","article-title":"Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure","volume":"15","author":"Morigi","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2005.07.011_bib85","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/01.ASN.0000125614.35046.10","article-title":"Evidence of tubular hypoxia in the early phase in the remnant kidney model","volume":"15","author":"Manotham","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2005.07.011_bib86","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1046\/j.1523-1755.2003.00885.x","article-title":"The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy","volume":"63","author":"Keane","year":"2003","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2005.07.011_bib87","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2169\/internalmedicine.43.9","article-title":"Mechanisms of tubulointerstitial injury in the kidney","volume":"43","author":"Nangaku","year":"2004","journal-title":"Intern Med"},{"key":"10.1053\/j.ackd.2005.07.011_bib88","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1681\/ASN.V1271448","article-title":"Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function","volume":"12","author":"Kang","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2005.07.011_bib89","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/ndt\/5.10.889","article-title":"Number of interstitial capillary cross-sections assessed by monoclonal antibodies","volume":"5","author":"Seron","year":"1990","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ackd.2005.07.011_bib90","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1046\/j.1523-1755.2000.00419.x","article-title":"Hypoxia promotes fibrogenesis in human renal fibroblasts","volume":"58","author":"Norman","year":"2000","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2005.07.011_bib91","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1097\/01.ASN.0000017223.49823.2A","article-title":"Expression of hypoxia-inducible factor-1alpha and -2alpha in hypoxic and ischemic rat kidneys","volume":"13","author":"Rosenberger","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2005.07.011_bib92","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/j.1523-1755.2004.00499.x","article-title":"Gene expression fingerprints in human tubulointerstitial inflammation and fibrosis as prognostic markers of disease progression","volume":"65","author":"Henger","year":"2004","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2005.07.011_bib93","first-page":"70","article-title":"The consequences for renal function of widening of the interstitium and changes in the tubular epithelium of the renal cortex and outer medulla in various renal diseases","volume":"37","author":"Mackensen-Haen","year":"1992","journal-title":"Clin Nephrol"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559505001242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559505001242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,18]],"date-time":"2021-07-18T04:43:10Z","timestamp":1626583390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548559505001242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":93,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S1548559505001242"],"URL":"https:\/\/doi.org\/10.1053\/j.ackd.2005.07.011","relation":{},"ISSN":["1548-5595"],"issn-type":[{"value":"1548-5595","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}